About Valence Labs
Valence Labs is Recursion’s frontier AI research engine. We lead high-impact research programs designed to materially expand Recursion’s ability to discover and develop medicines for complex diseases.
Our team balances near-term pragmatism with a long-term view of where the field is heading in the next 3–5 years, incubating, designing, and productizing the approaches we believe will define the future of drug discovery. Our work is driven by optimism, purpose, and a shared vision for a healthier tomorrow. We publish in top journals and conferences, contribute to open science, and engage with some of the world’s most active ML-for-drug-discovery research communities. Our teams are based in London and Montreal, with deep ties to Mila, the world’s largest deep-learning research institute.
About The Role
We are seeking a Research Scientist with a hybrid research-engineering mindset to join our team. In this role, you will be at the forefront of developing generative architectures and foundation models that ground machine learning in real-world physical and biological discovery. You will focus on accelerating and improving the accuracy of molecular design and structural biology workflows—specifically targeting the intersection of physics-informed frameworks and data-driven ML to solve complex protein-ligand interaction challenges.
Key Responsibilities
A successful candidate will have most of the following:
Working Location & Compensation:
This is an office-based, hybrid position at either of our offices located in Montreal, Quebec, Canada or in London, United Kingdom. Employees are expected to work in the office at least 50% of the time.
At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is:
You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.
#LI-EP1
£188,200 - £237,100
year
FULL TIME
Mid-Level
4/18/2026
You will be redirected to Valence Labs's application portal.